Your browser doesn't support javascript.
loading
Pulmonary and renal long COVID at two-year revisit.
Wang, Jing; Liang, Xiao; Zheng, Yufen; Zhu, Yi; Zhou, Kai; Wu, Xiaomai; Sun, Rui; Hu, Yifan; Zhu, Xiaoli; Chi, Hongbo; Chen, Shanjun; Lyu, Mengge; Xie, Yuting; Yi, Xiao; Liu, Wei; Cai, Xue; Li, Sainan; Zhang, Qiushi; Wu, Chunlong; Shi, Yingqiu; Wang, Donglian; Peng, Minfei; Zhang, Ying; Liu, Huafen; Zhang, Chao; Quan, Sheng; Kong, Ziqing; Kang, Zhouyang; Zhu, Guangjun; Zhu, Hongguo; Chen, Shiyong; Liang, Junbo; Yang, Hai; Pang, Jianxin; Fang, Yicheng; Chen, Haixiao; Li, Jun; Xu, Jiaqin; Guo, Tiannan; Shen, Bo.
Afiliação
  • Wang J; Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China.
  • Liang X; Key Laboratory of System Medicine and Precision Diagnosis and Treatment of Taizhou, Taizhou, Zhejiang, China.
  • Zheng Y; Taizhou Institute of Medicine, Health and New Drug Clinical Research, Taizhou, Zhejiang, China.
  • Zhu Y; Center for Intelligent Proteomics, Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, Zhejiang Province, China.
  • Zhou K; Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, Zhejiang Province, China.
  • Wu X; Research Center for Industries of the Future, Westlake University, Hangzhou, Zhejiang, China.
  • Sun R; Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China.
  • Hu Y; Key Laboratory of System Medicine and Precision Diagnosis and Treatment of Taizhou, Taizhou, Zhejiang, China.
  • Zhu X; Taizhou Institute of Medicine, Health and New Drug Clinical Research, Taizhou, Zhejiang, China.
  • Chi H; Center for Intelligent Proteomics, Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, Zhejiang Province, China.
  • Chen S; Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, Zhejiang Province, China.
  • Lyu M; Research Center for Industries of the Future, Westlake University, Hangzhou, Zhejiang, China.
  • Xie Y; Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China.
  • Yi X; Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China.
  • Liu W; Center for Intelligent Proteomics, Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, Zhejiang Province, China.
  • Cai X; Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, Zhejiang Province, China.
  • Li S; Research Center for Industries of the Future, Westlake University, Hangzhou, Zhejiang, China.
  • Zhang Q; Westlake Omics (Hangzhou) Biotechnology Co., Ltd, Hangzhou 310024, China.
  • Wu C; Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China.
  • Shi Y; Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China.
  • Wang D; Westlake Omics (Hangzhou) Biotechnology Co., Ltd, Hangzhou 310024, China.
  • Peng M; Center for Intelligent Proteomics, Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, Zhejiang Province, China.
  • Zhang Y; Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, Zhejiang Province, China.
  • Liu H; Research Center for Industries of the Future, Westlake University, Hangzhou, Zhejiang, China.
  • Zhang C; Center for Intelligent Proteomics, Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, Zhejiang Province, China.
  • Quan S; Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, Zhejiang Province, China.
  • Kong Z; Research Center for Industries of the Future, Westlake University, Hangzhou, Zhejiang, China.
  • Kang Z; Westlake Omics (Hangzhou) Biotechnology Co., Ltd, Hangzhou 310024, China.
  • Zhu G; Westlake Omics (Hangzhou) Biotechnology Co., Ltd, Hangzhou 310024, China.
  • Zhu H; Center for Intelligent Proteomics, Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, Zhejiang Province, China.
  • Chen S; Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, Zhejiang Province, China.
  • Liang J; Research Center for Industries of the Future, Westlake University, Hangzhou, Zhejiang, China.
  • Yang H; Center for Intelligent Proteomics, Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, Zhejiang Province, China.
  • Pang J; Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, Zhejiang Province, China.
  • Fang Y; Research Center for Industries of the Future, Westlake University, Hangzhou, Zhejiang, China.
  • Chen H; Westlake Omics (Hangzhou) Biotechnology Co., Ltd, Hangzhou 310024, China.
  • Li J; Westlake Omics (Hangzhou) Biotechnology Co., Ltd, Hangzhou 310024, China.
  • Xu J; Center for Intelligent Proteomics, Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, Zhejiang Province, China.
  • Guo T; Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, Zhejiang Province, China.
  • Shen B; Research Center for Industries of the Future, Westlake University, Hangzhou, Zhejiang, China.
iScience ; 27(7): 110344, 2024 Jul 19.
Article em En | MEDLINE | ID: mdl-39055942
ABSTRACT
This study investigated host responses to long COVID by following up with 89 of the original 144 cohorts for 1-year (N = 73) and 2-year visits (N = 57). Pulmonary long COVID, characterized by fibrous stripes, was observed in 8.7% and 17.8% of patients at the 1-year and 2-year revisits, respectively, while renal long COVID was present in 15.2% and 23.9% of patients, respectively. Pulmonary and renal long COVID at 1-year revisit was predicted using a machine learning model based on clinical and multi-omics data collected during the first month of the disease with an accuracy of 87.5%. Proteomics revealed that lung fibrous stripes were associated with consistent down-regulation of surfactant-associated protein B in the sera, while renal long COVID could be linked to the inhibition of urinary protein expression. This study provides a longitudinal view of the clinical and molecular landscape of COVID-19 and presents a predictive model for pulmonary and renal long COVID.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: IScience Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: IScience Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China